In DErrico’s and Cho’s dataset, higher expression levels of TEAD4 were found in gastric intestinal type adenocarcinoma (fold change = 6.960) and gastric adenocarcinoma (fold change = 2.015) [18, 19]. Here, TEAD4 is linked to gastric intestinal type adenocarcinoma.